Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)
| Autor: | S. Fujiwara, Masao Fukunaga, Osamu Chaki, Masaaki Inaba, Yasuo Imanishi, Junichi Takada, Noriko Yoshimura, Shoichi Ichimura, Takami Miki, Hiroshi Hagino, Masataka Shiraki, Yoshiki Nishizawa, Masakazu Miura, Hiroaki Ohta |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Clinical Biochemistry Osteoporosis Biochemistry Drug formulations Bone remodeling 03 medical and health sciences 0302 clinical medicine Japan medicine Humans Effective treatment Intensive care medicine Bone mineral Executive summary business.industry Biochemistry (medical) General Medicine medicine.disease Treatment efficacy 030104 developmental biology 030220 oncology & carcinogenesis Practice Guidelines as Topic Bone Remodeling business Biomarkers Combination drug |
| Zdroj: | Clinica Chimica Acta. 498:101-107 |
| ISSN: | 0009-8981 |
| DOI: | 10.1016/j.cca.2019.08.012 |
| Popis: | With the aging of society, the number of osteoporosis-related fractures is increasing. Prevention of osteoporosis and maintenance of the quality of life of osteoporosis patients require early diagnosis, effective treatment, and highly precise treatment monitoring. Although bone biopsy is clinically one of the essential techniques for diagnosis of osteoporosis, it is invasive and difficult to perform in general clinical practice. Bone mineral density measurement is another essential technique available in clinical practice that provides good precision. However, it is not effective for determining the appropriate treatment options or evaluating short-term treatment efficacy. On the other hand, bone turnover markers (BTMs) have gained attention because they provide information that is valuable for both the selection of treatment and short-term monitoring. BTMs are now positioned to become a tool for clinically assessing bone turnover outcomes. Since the Japan Osteoporosis Society issued its Guidelines for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis in 2012, new drugs, drug formulations, and combination drug therapies have been approved; therefore, we updated the 2012 guidelines in the Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect